🔎 Trials Near Me

Home › Cancro ai polmoni › Minnesota

Studi clinici su Cancro ai polmoni nello stato di Minnesota

42 studi su Cancro ai polmoni cercano partecipanti presso sedi nello stato di Minnesota.

Città nello stato di Minnesota

Testo ufficiale dello studio (inglese)

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

  • Sanford Joe Lueken Cancer Center, Bemidji
  • Minnesota Oncology - Burnsville, Burnsville
  • Mercy Hospital, Coon Rapids
  • e altri 16
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 2 ott 2026 · NCT04267848

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

  • Riverwood Healthcare Center, Aitkin
  • Mayo Clinic Health System in Albert Lea, Albert Lea
  • Essentia Health - Baxter Clinic, Baxter
  • e altri 48
In reclutamentoStudio osservazionaleVolontari sani benvenuti
Età da 40 a 75 · Tutti i sessi · Aggiornato il 2 ott 2026 · NCT05334069

Cemiplimab and Fianlimab Before Surgery for the Treatment of Stage IB-IIIB Non-Small Cell Lung Cancer

  • Mayo Clinic in Rochester, Rochester
In reclutamentoFase 2
Età 18 e oltre · Tutti i sessi · Aggiornato il 1 ott 2026 · NCT06918132

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

  • Health Partners Frauenshuh Cancer Center, Saint Louis Park
  • Health Partners Cancer Center at Regions Hospital, Saint Paul
In reclutamentoFase 2
Età 18 e oltre · Tutti i sessi · Aggiornato il 1 ott 2026 · NCT06172478

Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial

  • Sanford Joe Lueken Cancer Center, Bemidji
  • Minnesota Oncology - Burnsville, Burnsville
  • Mercy Hospital, Coon Rapids
  • e altri 15
In reclutamentoFase 3
Età 70 e oltre · Tutti i sessi · Aggiornato il 1 ott 2026 · NCT06096844

Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer

  • Minnesota Oncology - Burnsville, Burnsville
  • Mercy Hospital, Coon Rapids
  • Fairview Southdale Hospital, Edina
  • e altri 11
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 1 ott 2026 · NCT04181060

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

  • Sanford Joe Lueken Cancer Center, Bemidji
  • Essentia Health Saint Joseph's Medical Center, Brainerd
  • Mercy Hospital, Coon Rapids
  • e altri 12
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 1 ott 2026 · NCT06498635

A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)

  • Allina Health Cancer Institute - Abbott Northwestern Hospital ( Site 0027), Minneapolis
  • Mayo Clinic - Rochester ( Site 0073), Rochester
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 25 set 2026 · NCT06312137

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

  • Minnesota Oncology Hematology, P.A., Burnsville
  • Minnesota Oncology Hematology, P.A., Chaska
  • Allina Health Cancer Institute - Mercy Hospital, Coon Rapids
  • e altri 7
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 25 set 2026 · NCT07222566

This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.

  • Minnesota Oncology Hematology, PA, Burnsville
  • Minnesota Oncology Hematology PA, Coon Rapids
  • M Health Fairview Cancer Clinic-Edina, Edina
  • e altri 10
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 25 set 2026 · NCT06758401

A Study to Investigate Ubamatamab With and Without Marlotamig (REGN7075) in Adult Participants With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)

  • Mayo Clinic, Rochester
In reclutamentoFase 2
Età 18 e oltre · Tutti i sessi · Aggiornato il 25 set 2026 · NCT07154290

RMT in Combination With Durvalumab + Chemo in Untreated Adenocarcinoma NSCLC. A Randomized Double Blind Phase II Trial

  • MNCCTN Essentia Health St. Joseph's Brainerd Medical Center, Brainerd
  • MNCCTN Essentia Health Deer River, Deer River
  • MNCCTN Essentia Health St. Mary's Detroit Lakes Clinic, Detroit Lakes
  • e altri 6
In reclutamentoFase 2
Età 18 e oltre · Tutti i sessi · Aggiornato il 17 set 2026 · NCT04105270

Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies

  • Masonic Cancer Center University of Minnesota, Minneapolis
In reclutamentoFase 1/2
Età 18 e oltre · Tutti i sessi · Aggiornato il 16 set 2026 · NCT05786924

Molecular Analysis of Suspected or High-Risk Lung Cancer to Drive Individualized Care

  • Mayo Clinic in Rochester, Rochester
In reclutamentoStudio osservazionale
Età 18 e oltre · Tutti i sessi · Aggiornato il 8 set 2026 · NCT06482073

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

  • Allina Health Cancer Institute - Abbott Northwestern Hospital, Minneapolis
  • HealthPartners Cancer Research Center, Saint Paul
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 8 set 2026 · NCT06119581

The Vanguard Study: Testing a New Way to Screen for Cancer

  • Minneapolis VA Medical Center, Minneapolis
In reclutamentoVolontari sani benvenuti
Età da 45 a 75 · Tutti i sessi · Aggiornato il 2 set 2026 · NCT06995898

A Tool for Improving the Shared Decision-making Process in Patients With Non-small Cell Lung Cancer

  • Mayo Clinic in Rochester, Rochester
In reclutamentoVolontari sani benvenuti
Età 18 e oltre · Tutti i sessi · Aggiornato il 20 ago 2026 · NCT06122064

Evaluation of the Safety and Efficacy of Abenacianine (VGT-309) to Identify Cancer in Subjects Undergoing Surgery for Cancer in the Lung

  • Mayo Clinic, Rochester
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 19 ago 2026 · NCT07499674

Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial

  • Mayo Clinic in Rochester, Rochester
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 17 ago 2026 · NCT06500481

Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer

  • Sanford Joe Lueken Cancer Center, Bemidji
  • Essentia Health Saint Joseph's Medical Center, Brainerd
  • Essentia Health - Deer River Clinic, Deer River
  • e altri 8
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 17 ago 2026 · NCT05624996

Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma

  • Xencor Investigative Site, Rochester
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 3 ago 2026 · NCT05433142

Integrated Cancer Repository for Cancer Research

  • Riverwood Healthcare Center, Aitkin
  • Essentia Health-St. Joseph's Medical Center, Brainerd
  • Essentia Health - Duluth Clinic, Duluth
  • e altri 2
In reclutamentoStudio osservazionaleVolontari sani benvenuti
Età da 19 a 110 · Tutti i sessi · Aggiornato il 29 giu 2026 · NCT02012699

Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer

  • University of Minnesota, Minneapolis
In reclutamentoFase 2
Età da 18 a 70 · Tutti i sessi · Aggiornato il 26 giu 2026 · NCT04614103

Evaluation of Anti-PD-1 Therapy by Monitoring T Cell Responses in Melanoma, Lung and Other Cancer Types

  • Mayo Clinic in Rochester, Rochester
In reclutamentoStudio osservazionale
Età 18 e oltre · Tutti i sessi · Aggiornato il 18 giu 2026 · NCT06075524

A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression

  • Mayo Clinic Rochester, Rochester
In reclutamentoFase 1/2
Età 18 e oltre · Tutti i sessi · Aggiornato il 12 giu 2026 · NCT06051695

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

  • Sanford Joe Lueken Cancer Center, Bemidji
  • Mercy Hospital, Coon Rapids
  • Essentia Health - Deer River Clinic, Deer River
  • e altri 10
In reclutamentoFase 2
Età 18 e oltre · Tutti i sessi · Aggiornato il 3 giu 2026 · NCT05642572

The Sarah Nanotechnology System for Treatment of Advanced Metastatic Solid Tumors Using Hyperthermia.

  • Mayo Clinic, Rochester
In reclutamento
Età 18 e oltre · Tutti i sessi · Aggiornato il 15 mag 2026 · NCT07224464

Study to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC Patients

  • Mayo Clinic Cancer Center, Rochester
In reclutamentoFase 1/2
Età 18 e oltre · Tutti i sessi · Aggiornato il 14 mag 2026 · NCT06922591

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

  • Sanford Joe Lueken Cancer Center, Bemidji
  • Essentia Health - Deer River Clinic, Deer River
  • Essentia Health Cancer Center, Duluth
  • e altri 3
In reclutamentoFase 2
18 Minutes · Tutti i sessi · Aggiornato il 5 mag 2026 · NCT06031688

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

  • Sanford Joe Lueken Cancer Center, Bemidji
  • Essentia Health Saint Joseph's Medical Center, Brainerd
  • Mercy Hospital, Coon Rapids
  • e altri 13
In reclutamentoFase 2/3
Età 18 e oltre · Tutti i sessi · Aggiornato il 5 mag 2026 · NCT06616584

Axelopran for Advanced Cancer in Patients Receiving Opioids

  • HealthPartners Frauenshuh Cancer Research Center, Saint Louis Park
  • HealthPartners Cancer Center at Regions Hospital, Saint Paul
In reclutamentoFase 2
Età 18 e oltre · Tutti i sessi · Aggiornato il 5 mag 2026 · NCT07354919

Grid Radiation Therapy for the Treatment of Stage IV Non-Small Cell Lung Cancer

  • Mayo Clinic in Rochester, Rochester
In reclutamentoFase 2
Età 18 e oltre · Tutti i sessi · Aggiornato il 13 apr 2026 · NCT06660407

Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss

  • Mayo Clinic Cancer Center, Rochester
In reclutamentoFase 1/2
Età 18 e oltre · Tutti i sessi · Aggiornato il 13 apr 2026 · NCT06810544

Avera Cancer Sequencing and Analytics Protocol (ASAP)

  • Avera Cancer Institute - Marshall, Marshall
In reclutamentoStudio osservazionale
Età 18 e oltre · Tutti i sessi · Aggiornato il 27 mar 2026 · NCT05142033

Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy

  • Minneapolis VA Health Care System, Minneapolis, MN, Minneapolis
In reclutamento
Età 18 e oltre · Tutti i sessi · Aggiornato il 19 feb 2026 · NCT02984761

Insomnia in Patients With Metastatic Lung Cancer

  • Mayo Clinic in Rochester, Rochester
In reclutamentoStudio osservazionale
Età 18 e oltre · Tutti i sessi · Aggiornato il 4 feb 2026 · NCT06472804

cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease

  • Allina Health Cancer Institute, Minneapolis
  • Mayo Clinic, Rochester
In reclutamentoStudio osservazionaleVolontari sani benvenuti
Età 40 e oltre · Tutti i sessi · Aggiornato il 20 gen 2026 · NCT05366881

Thoracic Specimen Registry

  • Mayo Clinic in Rochester, Rochester
In reclutamentoStudio osservazionale
Età 18 e oltre · Tutti i sessi · Aggiornato il 16 gen 2026 · NCT04118660

LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia

  • Minnesota Oncology - Burnsville, Burnsville
  • Mercy Hospital, Coon Rapids
  • Fairview Southdale Hospital, Edina
  • e altri 18
In reclutamentoStudio osservazionale
Età 18 e oltre · Tutti i sessi · Aggiornato il 9 gen 2026 · NCT06073431

Fonte: ClinicalTrials.gov, dati recuperati il 5 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.